SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is experiencing significant market interest driven by reports that Nelson Peltz's Trian Fund Management is actively seeking financing to take the company private. This potential buyout, coupled with a high level of short interest, has led the community to actively discuss the setup for a potential short squeeze as investors bet on the company's long-term value despite recent downward analyst pressure.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is gaining momentum as investors pivot toward its potential in AI data center infrastructure and defense, with the community closely tracking institutional accumulation and rumors of upcoming OEM partnerships. Sentiment remains sharply divided between long-term holders betting on the company's solid-state battery technology and traders frustrated by periods of consolidation and the lack of immediate contract announcements.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense volatility as retail investors drive a potential gamma squeeze, drawing parallels to past momentum runners in the semiconductor and memory sectors. Community sentiment is overwhelmingly bullish, with many focused on the stock's role in Edge AI infrastructure and speculating that limited float could fuel significant further upside.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology Group Ltd (WOK) has become a focal point of intense community discussion, driven by extreme price volatility and a series of intraday trading halts that have fueled both massive short squeezes and aggressive profit-taking. Traders are actively debating whether the stock's parabolic moves, which echo typical patterns seen in other high-risk Chinese micro-cap tickers, represent a genuine growth catalyst or an unsustainable pump-and-dump setup.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense volatility as investors debate whether recent price swings are a healthy consolidation or a bubble pop fueled by a valuation disconnect in the memory sector. The community is actively tracking institutional accumulation, potential supply chain shifts from a Samsung labor strike, and the aggressive hedging activity of market-on-close algorithms during the final power hour of trading.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors react to the NRC's approval of the Principal Design Criteria for its Aurora powerhouse, a major regulatory milestone that de-risks the path toward commercial deployment. The community remains highly focused on the company's pre-revenue status, with active debate surrounding management's cash burn, upcoming earnings, and the stock's potential for a short squeeze given its high interest and critical role in the expanding AI energy infrastructure.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is seeing significant trading activity driven by a strong earnings report that showcased substantial revenue growth and the successful integration of recent semiconductor acquisitions. The community is actively discussing the stock's potential for a short squeeze, fueled by high short interest and institutional interest as the company shifts from research to commercial-scale production.

Roundhill ETF Trust - Roundhill Memory ETF

Investors are actively accumulating shares of the Roundhill Memory ETF, viewing recent volatility as a strategic entry point into the structural AI memory supercycle. The community remains overwhelmingly bullish on the long-term supply crunch for DRAM and HBM, frequently citing the ETF as a rare and efficient way to access key South Korean leaders like SK Hynix and Samsung alongside domestic semiconductor giants.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is rallying as investors position themselves ahead of a highly anticipated IPO from its partner, Cerebras Systems. The community is actively discussing the potential for a massive rerating, with many drawing parallels to successful AI infrastructure plays while dismissing short-sellers as the stock nears double-digit levels.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is attracting significant investor attention as they debate whether the stock is a deep-value opportunity or a value trap, with the community closely tracking the company's transition toward agentic AI orchestration and enterprise integration partnerships. While investors express frustration over persistent share price weakness and perceived market manipulation, others are aggressively accumulating shares, citing UiPath's strong cash position, debt-free balance sheet, and long-term growth potential as the market rotates back toward quality AI software.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here Are Monday's Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy's, and More

Here Are Monday's Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy's, and More...

Sanford C. Bernstein Cuts BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $82.00

Sanford C. Bernstein reduced their target price on shares of BioMarin Pharmaceutical from $94.00 to $82.00 and set an "outperform" rating for the company in a report on Tuesday...

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

BMRN misses Q1 EPS estimates despite a revenue beat, as charges and higher costs weigh on profits, while new Amicus deal lifts the 2026 outlook.

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $119.00 at Morgan Stanley

Morgan Stanley lowered their price target on shares of BioMarin Pharmaceutical from $120.00 to $119.00 and set an 'overweight' rating on the stock in a report on Tuesday...

Royal Bank Of Canada Reaffirms Sector Perform Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)

Royal Bank Of Canada reissued a "sector perform" rating and set a $66.00 price target on shares of BioMarin Pharmaceutical in a research report on Tuesday...

Compared to Estimates, BioMarin (BMRN) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for BioMarin (BMRN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

BioMarin Pharmaceutical Q1 Earnings Call Highlights

BioMarin Pharmaceutical (NASDAQ:BMRN) executives emphasized an expanded commercial portfolio and an updated 2026 growth outlook during the company's first-quarter 2026 earnings call, highlighted by...

Transcript: Biomarin Pharmaceutical Q1 2026 Earnings Conference Call

BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates

BioMarin (BMRN) delivered earnings and revenue surprises of -18.96% and +0.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

BioMarin Pharmaceutical (NASDAQ:BMRN) Issues Earnings Results

BioMarin Pharmaceutical (NASDAQ:BMRN - Get Free Report) posted its earnings results on Monday. The biotechnology company reported $0.76 earnings per share for the quarter, missing analysts' consensus estimates of $0.94 by ($0.18). The business had revenue of $766.21 million for the quarter...

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

BMRN
Biomarin Pharmaceutical Inc. - Registered Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest BMRN News

BMRNBiomarin Pharmaceutical Inc. - Registered Shares